India, Sept. 9 -- COVID-19 has affected 19 sectors in India that were not under stress earlier, with a total Rs 15.5 lakh crore outstanding debt; retail and wholesale trade most affected

Pharmaceutical company AstraZeneca Plc halted global trials of the vaccine it was developing against the novel coronavirus disease (COVID-19) because of a serious adverse reaction in a participant, the company said September 9, 2020.

* The company said the halt was "a routine action whenever there is a potentially unexplained illness in one of the trials", reported news daily The New York Times. It is unclear till when the trial will be halted.

* AstraZeneca's share price dipped 12 per cent to Rs 3,650 in the Bombay Stock Exchange, reported Financial E...